Ignite Creation Date:
2025-12-25 @ 3:24 AM
Ignite Modification Date:
2026-01-12 @ 3:02 AM
Study NCT ID:
NCT03002805
Status:
UNKNOWN
Last Update Posted:
2019-08-19
First Post:
2016-12-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin
Sponsor:
CBA Research
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-29
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-09
Completion Date Type:
ESTIMATED
First Submit Date:
2016-12-15
First Submit QC Date:
None
Study First Post Date:
2016-12-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-08-16
Last Update Post Date:
2019-08-19
Last Update Post Date Type:
ACTUAL